The path to understanding and overcoming late-stage cancer begins with Intermountain Precision Genomics' TheraMap test, a personalized approach to cancer care.
By matching your patients with prioritized treatment options and appropriate clinical trials, we can help you deliver better outcomes and reduce costs. This way, your patients can spend less time worrying about their treatment and have more quality time with those who matter most.
TheraMap is a hybrid capture DNA and RNA based test that detects SNV, INDELs, Copy Number Amplifications (CNV), and Fusions in solid tumors. In contrast to amplicon or other targeted methods, TheraMap has a hybrid capture technology that is one of the most sensitive methodologies for detecting gene fusion events from known and novel partners. TheraMap is one of the only panels that can detect any oncogenic fusion event in NTRK1, NTRK2, and NTRK3, a critical biomarker with the recent approval of Vitrakvi (larotrectinib).
TheraMap tests 170 genes. View the full list of genes here.
When TheraMap is ordered by an oncologist, the process starts by securing the tumor specimen for processing. With all the logistics and paperwork taken care of, it’s easier to focus on what’s important: caring for your patients.
Sequencing and bioinformatics
Utilizing state-of-the-art next-generation sequencing, additional molecular methods, and proprietary data analytics, we identify all clinically relevant cancer mutations. This comprehensive tumor profile serves as the foundation for Intermountain Healthcare's molecular tumor board to analyze and prioritize treatment options.
Molecular tumor board
We provide access to Intermountain Healthcare’s molecular tumor board, a multi-institutional group of clinical experts and precision medicine key opinion leaders. Using a multi-disciplinary approach, they’ll provide a ﬁrm recommendation for treatment with one speciﬁc therapy highlighted and others stack-ranked below it. Treatment decisions should always be made by the oncologist and the individual patient.
A report is returned back to the ordering provider with treatment information on variants that are clinically actionable and a list of available clinical trials.
- If you have a provider login, place an order through the portal.
- If you are a new ordering provider, download the order form here and fax the completed form to (435) 251-5781.
Please reference this document for specimen and shipping requirements.
Billing and Insurance Information
While some insurance companies cover genetic testing, please work with the patient’s insurance company for any pre-authorization requirements prior to ordering. If you have any questions, or would like assistance, please call our customer service representatives at (435) 251-5780.